
Ernexa Therapeutics (NASDAQ: ERNA) is developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease. Ernexa's core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa's a... Ernexa Therapeutics (NASDAQ: ERNA) is developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease. Ernexa's core technology focuses on engineering induced pluripotent stem cells (iPSCs) and transforming them into induced mesenchymal stem cells (iMSCs). Ernexa's allogeneic synthetic iMSCs provide a scalable, off-the-shelf treatment solution, without needing patient-specific cell harvesting. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0725 | 3.1798245614 | 2.28 | 2.65 | 2.28 | 88046 | 2.51641557 | CS |
4 | -1.0975 | -31.8115942029 | 3.45 | 3.6615 | 2.08 | 739712 | 2.76634539 | CS |
12 | -0.3025 | -11.3935969868 | 2.655 | 4.0185 | 2.08 | 348170 | 2.88928999 | CS |
26 | -1.4575 | -38.2545931759 | 3.81 | 14.4 | 2.08 | 5393433 | 6.69944631 | CS |
52 | -26.2975 | -91.7888307155 | 28.65 | 39.375 | 2.08 | 2835193 | 6.64502682 | CS |
156 | -60.6475 | -96.2658730159 | 63 | 107.25 | 2.08 | 1073675 | 7.65132493 | CS |
260 | -60.6475 | -96.2658730159 | 63 | 107.25 | 2.08 | 1073675 | 7.65132493 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約